Pathology at Johns Hopkins

The Department of Pathology at Johns Hopkins is preeminent nationally and globally in the study and treatment of human disease and in professional training in all areas of pathology and laboratory science. Currently, there are over 1400 people in the department, which includes approximately 120 full-time faculty, 36 residents, 45 graduate students, over 100 fellows, and 1000 staff members.

Grand Rounds

<< Archives | This Year >>

TODAY at 8:30 am

Admissions at Johns Hopkins Medical School
Allan Gelber, MD, PhD, MPH


Publications Spotlighted

Johns Hopkins Pathology Takes Center Stage:

Johns Hopkins Pathology has been the number one NIH funded pathology department for 11 of the past 12 years.


Our research interests span a broad area— we highlighted a few research discoveries.



View All Publications



Pathology Blog

Loading Blog Feeds


Other Department Blogs

Loading Blog Feeds



What's New?

Hopkins Scientists Discover a New Type of Immune Cell

May 30, 2019

X Cell
A team of scientists in the Department of Pathology, led by Abdel Rahim A. Hamad, D.V.M., Ph.D., report, in the May 30th advance on-line edition of the journal Cell, the remarkable discovery of a new type of immune cell. Historically T and B cells have been thought of as distinct arms of the immune system, Dr. Hamad and colleagues have discovered a rare cell that they call the X cell, that has features of both T and B cells. They further show that the newly discovered X cell may play a role in the development of type 1 diabetes. Congratulations to Dr. Hamad and his team on this very exciting discovery!

Click here for the press release.
Click here for the article in Cell



New Blood Test for Cancer

May 30, 2019

DELFI
A team of scientists at Johns Hopkins, led by Victor Velculescu, M.D.,Ph.D., report a new approach to a blood test for cancer. Reported in the journal Nature, the test can be used to detect seven different types of cancer, including pancreatic cancer. The test, called "DELFI" (DNA evaluation of fragments for early interception) detects abnormal fragments of DNA in the blood that have been shed by cancer cells. This technique takes advantage of the fact that cancers "package" their DNA differently than normal cells, and this unique packaging leads to unique patterns of DNA fragmentation that can be detected in the blood. DELFI detected close to 75% of cancer patients, and, remarkably, when combined with another blood test, DELFI could detect 91% of cancers.

Click here for the press release.



Congratulations, Dr. Danielle Hutchings!

May 24, 2019

Danielle Hutchings, M.D.
Congratulations to our resident Danielle Hutchings, M.D.! Danielle was awarded the Frank Coulson Jr. Award for Clinical Excellence from the Miller Coulson Academy of Clinical Excellence here at Hopkins. The Miller Coulson Academy of Clinical Excellence recognizes and promotes excellence in patient care at Johns Hopkins for the benefit of the individuals and communities that we serve. The academy recognizes clinically excellent academic physicians who have achieved a level of mastery in communication & interpersonal skills, professionalism & humanism, and negotiation of the healthcare system. Congratulations Danielle!



All Pathology News >>


Best Hospitals in the World